Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Assessment circulating micro-RNA-192 in Egyptian patients with non-viral liver cirrhosis and hepatocellular carcinoma
by
Soliman, Ayman S.
, Gaber, Safy S.
, Abujamai, Jakleen Z.
, Damanhory, Ahmed A.
, Elagali, Abdallah Mohammed
, Huzien, Alaa H.
, Abdelaziz, Mohamed Abdelaleim
, Sakr, Hader I.
, Ibrahim, Ahmed A.
in
Alpha fetoprotein
/ And microRNA‑192
/ Cancer Research
/ Enzymes
/ Hepatic cirrhosis
/ Hepatocellular carcinoma
/ Hospitals
/ Internal Medicine
/ Liver cancer
/ Liver cirrhosis
/ Liver diseases
/ Medical prognosis
/ Medicine
/ Medicine & Public Health
/ MicroRNAs
/ Molecular Medicine
/ Oncology
/ Patients
/ Radiotherapy
/ Regression analysis
/ Surgical Oncology
2026
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Assessment circulating micro-RNA-192 in Egyptian patients with non-viral liver cirrhosis and hepatocellular carcinoma
by
Soliman, Ayman S.
, Gaber, Safy S.
, Abujamai, Jakleen Z.
, Damanhory, Ahmed A.
, Elagali, Abdallah Mohammed
, Huzien, Alaa H.
, Abdelaziz, Mohamed Abdelaleim
, Sakr, Hader I.
, Ibrahim, Ahmed A.
in
Alpha fetoprotein
/ And microRNA‑192
/ Cancer Research
/ Enzymes
/ Hepatic cirrhosis
/ Hepatocellular carcinoma
/ Hospitals
/ Internal Medicine
/ Liver cancer
/ Liver cirrhosis
/ Liver diseases
/ Medical prognosis
/ Medicine
/ Medicine & Public Health
/ MicroRNAs
/ Molecular Medicine
/ Oncology
/ Patients
/ Radiotherapy
/ Regression analysis
/ Surgical Oncology
2026
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Assessment circulating micro-RNA-192 in Egyptian patients with non-viral liver cirrhosis and hepatocellular carcinoma
by
Soliman, Ayman S.
, Gaber, Safy S.
, Abujamai, Jakleen Z.
, Damanhory, Ahmed A.
, Elagali, Abdallah Mohammed
, Huzien, Alaa H.
, Abdelaziz, Mohamed Abdelaleim
, Sakr, Hader I.
, Ibrahim, Ahmed A.
in
Alpha fetoprotein
/ And microRNA‑192
/ Cancer Research
/ Enzymes
/ Hepatic cirrhosis
/ Hepatocellular carcinoma
/ Hospitals
/ Internal Medicine
/ Liver cancer
/ Liver cirrhosis
/ Liver diseases
/ Medical prognosis
/ Medicine
/ Medicine & Public Health
/ MicroRNAs
/ Molecular Medicine
/ Oncology
/ Patients
/ Radiotherapy
/ Regression analysis
/ Surgical Oncology
2026
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Assessment circulating micro-RNA-192 in Egyptian patients with non-viral liver cirrhosis and hepatocellular carcinoma
Journal Article
Assessment circulating micro-RNA-192 in Egyptian patients with non-viral liver cirrhosis and hepatocellular carcinoma
2026
Request Book From Autostore
and Choose the Collection Method
Overview
Background
It is challenging to diagnose hepatic cirrhosis and hepatocellular carcinoma (HCC) at an early stage since non-invasive markers are not specific and do not identify the early stage.
Objective
Serum microRNA-192 could represent an early and critical pathogenetic factor in different liver diseases.
Methods
92 participants were allocated into four equal groups (
n
= 23): control, compensated liver cirrhosis, decompensated cirrhosis, and HCC groups.
Results
Decompensated cirrhosis and HCC showed significantly elevated Serum Alanine aminotransferase, aspartate aminotransferase, bilirubin, alpha-fetoprotein, and microRNA-192.
Conclusion
Serum microRNA-192 can predict decompensated liver cirrhosis and HCC with high sensitivity and specificity.
This website uses cookies to ensure you get the best experience on our website.